Paper42423830
Inhibition of miR-25-3p Alleviates Neuroinflammation in Alzheimer's Disease By Targeting ADAM10.
Chen P and 5 others. Mol Neurobiol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of miR-25-3p Alleviates Neuroinflammation in Alzheimer's Disease By Targeting ADAM10. Papers, record 42423830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42423830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of miR-25-3p Alleviates Neuroinflammation in Alzheimer's Disease By Targeting ADAM10.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Alzheimer Disease | Major topic |
| ADAM10 Protein | Major topic |
| Amyloid Precursor Protein Secretases | Major topic |
| Membrane Proteins | Major topic |
| Neuroinflammatory Diseases | Major topic |
| Humans | |
| Female | |
| Male | |
| Amyloid beta-Peptides | |
| Cell Line, Tumor | |
| Apoptosis | |
| Aged | |
| Cell Proliferation | |
| Up-Regulation | |
| Peptide Fragments |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34749366 | Differential Expression of miR-381-3p in Alzheimer's Disease Patients and Its Role in Beta-Amyloid-Induced Neurotoxicity and Inflammation. | Neuroimmunomodulation | 2022 | https://conductscience.org/library/papers/34749366 | PubMed |
| 2 | 31223109 | [miR-25-3p down-regulates the expression of ADAM10 to inhibit the differentiation of P19 cells into cardiomyocytes by blocking the Notch signaling pathway]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2019 | https://conductscience.org/library/papers/31223109 | PubMed |
| 3 | 28782488 | MicroRNA Dysregulation in Alzheimer's Disease. | CNS Neurol Disord Drug Targets | 2017 | https://conductscience.org/library/papers/28782488 | PubMed |
| 4 | 29253717 | Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease. | Neurobiol Aging | 2018 | https://conductscience.org/library/papers/29253717 | PubMed |
| 5 | 18701698 | Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. | J Neurosci | 2008 | https://conductscience.org/library/papers/18701698 | PubMed |
| 6 | 25604547 | Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. | Acta Neuropathol | 2015 | https://conductscience.org/library/papers/25604547 | PubMed |
| 7 | 28862638 | Microglia in Alzheimer's disease. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28862638 | PubMed |
| 8 | 31564456 | Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. | Cell | 2019 | https://conductscience.org/library/papers/31564456 | PubMed |
| 9 | 32712875 | miR-29c-3p Increases Cell Viability and Suppresses Apoptosis by Regulating the TNFAIP1/NF-κB Signaling Pathway via TNFAIP1 in Aβ-Treated Neuroblastoma Cells. | Neurochem Res | 2020 | https://conductscience.org/library/papers/32712875 | PubMed |
| 10 | 33683313 | Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial. | JAMA Neurol | 2021 | https://conductscience.org/library/papers/33683313 | PubMed |
| 11 | 26426747 | Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers. | PLoS One | 2015 | https://conductscience.org/library/papers/26426747 | PubMed |
| 12 | 32871216 | Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Aβ-induced neurotoxicity by regulating JAK2. | Exp Gerontol | 2020 | https://conductscience.org/library/papers/32871216 | PubMed |
| 13 | 36533182 | The role of ADAM10 in astrocytes: Implications for Alzheimer's disease. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/36533182 | PubMed |
| 14 | 23964211 | Inflammatory process in Alzheimer's Disease. | Front Integr Neurosci | 2013 | https://conductscience.org/library/papers/23964211 | PubMed |
| 15 | 31456514 | Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer's Disease and Involvement of Neuroinflammation. | Curr Alzheimer Res | 2019 | https://conductscience.org/library/papers/31456514 | PubMed |
| 16 | 30045733 | Levels of ADAM10 are reduced in Alzheimer's disease CSF. | J Neuroinflammation | 2018 | https://conductscience.org/library/papers/30045733 | PubMed |
| 17 | 32474742 | MicroRNA miR-212 regulates PDCD4 to attenuate Aβ25-35-induced neurotoxicity via PI3K/AKT signaling pathway in Alzheimer's disease. | Biotechnol Lett | 2020 | https://conductscience.org/library/papers/32474742 | PubMed |
| 18 | 28409746 | The Role of ADAM10 in Alzheimer's Disease. | J Alzheimers Dis | 2017 | https://conductscience.org/library/papers/28409746 | PubMed |
| 19 | 37092127 | Diminazene Ameliorates Neuroinflammation by Suppression of Astrocytic miRNA-224-5p/NLRP3 Axis in Alzheimer's Disease Model. | J Inflamm Res | 2023 | https://conductscience.org/library/papers/37092127 | PubMed |
| 20 | 33576470 | Potential of miR-25-3p in protection of chondrocytes: emphasis on osteoarthritis. | Folia Histochem Cytobiol | 2021 | https://conductscience.org/library/papers/33576470 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADAM10 | 102 | PubTator's text mining | https://conductscience.org/library/genes/102 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42423830
GET https://conductscience.org/api/papers/v1/42423830/references?page=2